ЦИ, Цзюнь (US),ТАНАКА, Минору (US),РОБЕРТС, Джастин, М. (US),БРАДНЕР, Джеймс И. (US)
申请号：
RU2018122641
公开号：
RU2018122641A
申请日:
2016.11.23
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V) and (VI). Some bromdomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases comprising the inventive compounds, as well as methods of using the inventive compounds.
